Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282867 · ClinicalTrials.gov registry record · Phase 2
Glucose Regulation in Acute Stroke Patients (GRASP) Study
A Phase 2 study, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
NCT00282867 is a Phase 2 study that has completed, run by University of Virginia. The registered enrollment target is 74 participants.
The verdict
NCT00282867, a Phase 2 study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility, safety and preliminary efficacy of the use of insulin infusions as treatment for hyperglycemic acute ischemic stroke patients.
Interventions
- OTHER standard care
- DRUG IV glucose insulin and potassium, GIK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2006-05 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00282867
The ClinicalTrials.gov registry entry for NCT00282867 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which standard care is the first listed.
NCT00282867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00282867 about?
NCT00282867 is a clinical study titled "Glucose Regulation in Acute Stroke Patients (GRASP) Study". The purpose of this study is to assess the feasibility, safety and preliminary efficacy of the use of insulin infusions as treatment for hyperglycemic acute ischemic stroke patients.
What is the current status of trial NCT00282867?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2006-05. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00282867?
The interventions under investigation include: standard care (OTHER), IV glucose insulin and potassium, GIK (DRUG).
Who is sponsoring clinical trial NCT00282867?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.